Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry

View source ↗

Summary

Completed status for the Paroxysmal nocturnal hemoglobinuria (PNH) Registry, an observational study sponsored by Alexion Pharmaceuticals to track patient outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Status: COMPLETED